Insider transactions

EDGAR

newcleo plc

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-17.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–16 of 16

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-21 Filed 2026-09-23Petrone Raffaele Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Class B Shares — underlying Ordinary Shares (2,030,119)
Acquired (A)2,030,1190—2,030,119Indirect (I) By FIN POSILLIPO S.p.A.No
F1
  • F1 Reflects the issuance of Class B Shares in accordance with that certain Business Combination Agreement, dated as of May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd.. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary Shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Open filing 0000950103-26-014414 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Buono Stefano Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (134,596) — exercise price 0.0228
Acquired (A)134,5960—134,596Direct (D) No
F1, F2
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  • F2 These stock options vest as to service on each of the first four anniversaries of December 1, 2025, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Open filing 0000950103-26-014418 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Buono Stefano Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (4,291) — exercise price 0.0228
Acquired (A)4,2910—4,291Direct (D) No
F1, F3
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  • F3 These stock options vest as to service on each of the first four anniversaries of September 1, 2023, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Open filing 0000950103-26-014418 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Buono Stefano Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (9,814) — exercise price 0.0228
Acquired (A)9,8140—9,814Direct (D) No
F1, F4
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  • F4 These stock options vest as to service on each of the first four anniversaries of September 1, 2022, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Open filing 0000950103-26-014418 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Buono Stefano Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Class B Shares — underlying Ordinary Shares (11,960)
Acquired (A)11,9600—11,960Direct (D) No
F5
  • F5 Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Open filing 0000950103-26-014418 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Buono Stefano Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Class B Shares — underlying Ordinary Shares (1,921,029)
Acquired (A)1,921,0290—1,921,029Indirect (I) By Elysia Capital I SCSpNo
F5
  • F5 Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Open filing 0000950103-26-014418 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Stranske Jon Officer: Group Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Ordinary Shares
Acquired (A)6,7290—74,027Direct (D) No
F1
  • F1 Reflects the grant of Company Earnout Bonus RSUs under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus RSUs vest as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus RSUs satisfy applicable service vesting conditions.
Open filing 0000950103-26-014415 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23de Bourdoncle de Saint Salvy Anne-Francois Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (3,432) — exercise price 0.0228
Acquired (A)3,4320—37,766Direct (D) No
F1, F2
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares in accordance with that certain Business Combination Agreement, dated as of May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). In accordance with the BCA, the Company Earnout Bonus Options will vest and become exercisable as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
  • F2 The Company Earnout Bonus Options are fully vested as to service.
Open filing 0000950103-26-014407 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Rizzotti Elisabeth Director · Officer: Deputy Ch Ex Off Ch Oper Off
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (96,140) — exercise price 0.0228
Acquired (A)96,1400—96,140Direct (D) No
F1, F2
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  • F2 These stock options vest as to service on each of the first four anniversaries of December 1, 2025, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Open filing 0000950103-26-014417 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Rizzotti Elisabeth Director · Officer: Deputy Ch Ex Off Ch Oper Off
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (3,759) — exercise price 0.0228
Acquired (A)3,7590—3,759Direct (D) No
F1, F3
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  • F3 These stock options vest as to service on each of the first four anniversaries of September 1, 2024, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Open filing 0000950103-26-014417 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Rizzotti Elisabeth Director · Officer: Deputy Ch Ex Off Ch Oper Off
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (7,416) — exercise price 0.0228
Acquired (A)7,4160—7,416Direct (D) No
F1, F4
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  • F4 These stock options vest as to service on each of the first four anniversaries of September 1, 2023, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Open filing 0000950103-26-014417 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Rizzotti Elisabeth Director · Officer: Deputy Ch Ex Off Ch Oper Off
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Ordinary Shares (12,418) — exercise price 0.0228
Acquired (A)12,4180—12,418Direct (D) No
F1, F5
  • F1 Reflects the grant of Company Earnout Bonus Options to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the BCA). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  • F5 These stock options vest as to service on each of the first four anniversaries of September 1, 2022, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Open filing 0000950103-26-014417 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Rizzotti Elisabeth Director · Officer: Deputy Ch Ex Off Ch Oper Off
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Class B Shares — underlying Ordinary Shares (32,447)
Acquired (A)32,4470—32,447Direct (D) No
F6
  • F6 Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary Shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Open filing 0000950103-26-014417 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Levi Andrea Ruben Osvaldo Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Class B Shares — underlying Ordinary Shares (374,946)
Acquired (A)374,9460—374,946Indirect (I) By Parabensa S.r.l.No
F1
  • F1 Reflects the issuance of Class B Shares in accordance with that certain Business Combination Agreement, dated as of May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd.. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary Shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Open filing 0000950103-26-014412 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Levi Andrea Ruben Osvaldo Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Class B Shares — underlying Ordinary Shares (110,561)
Acquired (A)110,5610—110,561Indirect (I) By DAL 1802 Educazione Cultura SaluteNo
F1
  • F1 Reflects the issuance of Class B Shares in accordance with that certain Business Combination Agreement, dated as of May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd.. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary Shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Open filing 0000950103-26-014412 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-23Lefebvre d'Ovidio Manfredi Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Class B Shares — underlying Ordinary Shares (326,049)
Acquired (A)326,0490—326,049Indirect (I) By Emmeplus LimitedNo
F1
  • F1 Reflects the issuance of Class B Shares in accordance with that certain Business Combination Agreement, dated as of May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd.. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary Shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Open filing 0000950103-26-014413 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-16. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–41 of 41

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Hudson Bay Capital Management LP 7,000,000 SH54,950,000 dollarsNot in the prior quarter’s filings read Open filing 0001393825-26-000083 Filed 2026-11-13 Dispute this row
Merewether Investment Management, LP 2,500,000 SH19,625,000 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002883 Filed 2026-11-16 Dispute this row
Graham Capital Management, L.P. 2,230,000 SH17,505,500 dollarsNot in the prior quarter’s filings read Open filing 0002048251-26-009806 Filed 2026-11-16 Dispute this row
LMR Partners LLP Partly reported under another manager1,417,492 SH4,253,303 dollarsNot in the prior quarter’s filings read Open filing 0001578621-26-000193 Filed 2026-11-16 Dispute this row
Linden Advisors LP 1,172,518 SH2,337,034 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-462390 Filed 2026-11-16 Dispute this row
MOORE CAPITAL MANAGEMENT, LP 725,000 SH4,835,000 dollarsNot in the prior quarter’s filings read Open filing 0001448574-26-000004 Filed 2026-11-16 Dispute this row
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 625,000 SH621,875 dollarsNot in the prior quarter’s filings read Open filing 0001535845-26-000011 Filed 2026-11-13 Dispute this row
MILLENNIUM MANAGEMENT LLC Option: Call 575,100 SH575,100 dollarsNot in the prior quarter’s filings read Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Magnetar Financial LLC 544,302 SH541,580 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-126450 Filed 2026-11-13 Dispute this row
AQR Arbitrage LLC 515,000 SH512,425 dollarsNot in the prior quarter’s filings read Open filing 0001167456-26-000005 Filed 2026-11-16 Dispute this row
Burkehill Global Management, LP 500,000 SH3,795,000 dollarsNot in the prior quarter’s filings read Open filing 0001013594-26-001202 Filed 2026-11-16 Dispute this row
ARISTEIA CAPITAL, L.L.C. Partly reported under another manager444,799 SH433,679 dollarsNot in the prior quarter’s filings read Open filing 0001080171-26-000012 Filed 2026-11-16 Dispute this row
Decagon Asset Management LLP 407,135 SH407,135 dollarsNot in the prior quarter’s filings read Open filing 0001950677-26-000026 Filed 2026-11-16 Dispute this row
Monashee Investment Management LLC 400,000 SH3,140,000 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-004876 Filed 2026-11-06 Dispute this row
TENOR CAPITAL MANAGEMENT COMPANY, L.P. 400,000 SH400,000 dollarsNot in the prior quarter’s filings read Open filing 0001346554-26-000092 Filed 2026-11-16 Dispute this row
Westchester Capital Management, LLC Partly reported under another manager398,677 SH2,955,827 dollarsNot in the prior quarter’s filings read Open filing 0001512805-26-000013 Filed 2026-11-12 Dispute this row
Alberta Investment Management Corp 387,500 SH385,563 dollarsNot in the prior quarter’s filings read Open filing 0001123292-26-001506 Filed 2026-11-09 Dispute this row
Lineage Point Capital LP 330,819 SH330,819 dollarsNot in the prior quarter’s filings read Open filing 0001214659-26-014355 Filed 2026-11-16 Dispute this row
CSS LLC/IL Partly reported under another manager300,118 SH300,118 dollarsNot in the prior quarter’s filings read Open filing 0001103646-26-000019 Filed 2026-11-16 Dispute this row
MMCAP International Inc. SPC 300,000 SH1,670,000 dollarsNot in the prior quarter’s filings read Open filing 0000912282-26-001452 Filed 2026-11-12 Dispute this row
Sculptor Capital LP Partly reported under another manager222,458 SH222,458 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-460943 Filed 2026-11-13 Dispute this row
LuminArx Capital Management LP 214,451 SH1,683,440 dollarsNot in the prior quarter’s filings read Open filing 0001992915-26-000004 Filed 2026-11-13 Dispute this row
Verition Fund Management LLC 203,506 SH202,488 dollarsNot in the prior quarter’s filings read Open filing 0001454027-26-000007 Filed 2026-11-13 Dispute this row
WOLVERINE ASSET MANAGEMENT LLC Partly reported under another manager189,132 SH189,132 dollarsNot in the prior quarter’s filings read Open filing 0001279891-26-000016 Filed 2026-11-02 Dispute this row
Mint Tower Capital Management B.V. Partly reported under another manager186,905 SH187 dollarsNot in the prior quarter’s filings read Open filing 0001666606-26-000008 Filed 2026-11-09 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager181,131 SH180,225 dollarsNot in the prior quarter’s filings read Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
PEAK6 LLC Partly reported under another manager151,572 SH151,572 dollarsNot in the prior quarter’s filings read Open filing 0001389958-26-000020 Filed 2026-11-13 Dispute this row
Calamos Advisors LLC 150,000 SH149,250 dollarsNot in the prior quarter’s filings read Open filing 0001316507-26-000004 Filed 2026-11-02 Dispute this row
Shaolin Capital Management LLC 150,000 SH150,000 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005001 Filed 2026-11-13 Dispute this row
WHITEBOX ADVISORS LLC 125,000 SH125,000 dollarsNot in the prior quarter’s filings read Open filing 0001257391-26-000008 Filed 2026-11-16 Dispute this row
K2 PRINCIPAL FUND, L.P. 107,874 SH107,874 dollarsNot in the prior quarter’s filings read Open filing 0001461790-26-000041 Filed 2026-11-13 Dispute this row
Walleye Capital LLC 106,100 SH106,100 dollarsNot in the prior quarter’s filings read Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager82,420 SH270,014 dollarsNot in the prior quarter’s filings read Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Clear Street Group Inc. 65,509 SH65,509 dollarsNot in the prior quarter’s filings read Open filing 0001881567-26-000006 Filed 2026-11-16 Dispute this row
Context Capital Management, LLC 50,000 SH50,000 dollarsNot in the prior quarter’s filings read Open filing 0001301396-26-000010 Filed 2026-11-04 Dispute this row
Saba Capital Management, L.P. 49,998 SH48,748 dollarsNot in the prior quarter’s filings read Open filing 0001062993-26-006091 Filed 2026-11-16 Dispute this row
Wealthspring Capital LLC 47,851 SH47,851 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000929 Filed 2026-11-04 Dispute this row
Centiva Capital, LP 47,000 SH46,765 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005016 Filed 2026-11-13 Dispute this row
Schonfeld Strategic Advisors LLC 42,407 SH42,407 dollarsNot in the prior quarter’s filings read Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row
CANTOR FITZGERALD, L. P. Partly reported under another manager31,864 SH31,705 dollarsNot in the prior quarter’s filings read Open filing 0000929638-26-004323 Filed 2026-11-16 Dispute this row
Parallax Volatility Advisers, L.P. 15,000 SH14,925 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005336 Filed 2026-11-16 Dispute this row
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Fin Posillipo S.p.A. Ordinary Shares, par value $0.02288 per share7.220,301,194.0009/21/2026 Filed 2026-11-12SCHEDULE 13GOpen filing 0000950103-26-017302 Dispute this row
Raffaele Petrone Ordinary Shares, par value $0.02288 per share7.220,301,194.0009/21/2026 Filed 2026-11-12SCHEDULE 13GOpen filing 0000950103-26-017302 Dispute this row
Simon Fiduciaria S.p.A. Ordinary Shares, par value $0.02288 per share5.415,079,795.0009/21/2026 Filed 2026-10-15SCHEDULE 13GOpen filing 0000950103-26-015614 Dispute this row
Elysia Capital I SCSp Ordinary Shares, par value $0.02288 per share.6.819,210,290.0009/21/2026 Filed 2026-10-15SCHEDULE 13GOpen filing 0000950103-26-015613 Dispute this row
Buono Stefano Ordinary Shares, par value $0.02288 per share.7.120,123,335.0009/21/2026 Filed 2026-10-15SCHEDULE 13GOpen filing 0000950103-26-015613 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,212,651 filings read, dated 2004-06-14 to 2026-11-16: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
2022130,393
2023199,811
2024209,823
2025235,520
2026260,165

Filings made before the SEC required XML are listed, not extracted.

Back to newcleo plc